BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7214714)

  • 21. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.
    Soyoral YU; Demir C; Begenik H; Esen R; Kucukoglu ME; Aldemir MN; Demirkiran D; Erkoc R
    Clin Appl Thromb Hemost; 2012; 18(2):185-8. PubMed ID: 22327827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral microencapsulated live Saccharomyces cerevisiae cells for use in renal failure uremia: preparation and in vivo analysis.
    Coussa R; Martoni C; Bhathena J; Urbanska AM; Prakash S
    J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20798777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are urea and creatinine uremic toxins in the rat?
    Levine S; Saltzman A
    Ren Fail; 2001 Jan; 23(1):53-9. PubMed ID: 11256529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profiling of uremic serum by high-resolution gas chromatography-electron-impact, chemical ionization mass spectrometry.
    Schoots AC; Mikkers FE; Cramers CA; Ringoir S
    J Chromatogr; 1979 Sep; 164(1):1-8. PubMed ID: 541389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of oral sorbent, AST-120, on serum concentration of indoxyl sulfate in uremic rats].
    Niwa T; Yazawa T; Maeda K; Ise M; Sugano M; Kodama T; Uehara Y
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):695-701. PubMed ID: 2120492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats.
    Niwa T; Yazawa T; Ise M; Sugano M; Kodama T; Uehara Y; Maeda K
    Nephron; 1991; 57(1):84-8. PubMed ID: 1904558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis.
    Hida M; Aiba Y; Sawamura S; Suzuki N; Satoh T; Koga Y
    Nephron; 1996; 74(2):349-55. PubMed ID: 8893154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of beta-aminoisobutyric acid in uremic serum.
    Gejyo F; Kinoshita Y; Ikenaka T
    Clin Chim Acta; 1976 Aug; 70(3):407-15. PubMed ID: 947634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum creatinine concentration at the onset of uremia: higher levels in black males.
    Abuelo JG; Shemin D; Chazan JA
    Clin Nephrol; 1992 Jun; 37(6):303-7. PubMed ID: 1638782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Retention of medium sized molecules in uremic serum].
    Dall'aglio P; Buzio C; Cambi V; Arisi L; Migone L
    Proc Eur Dial Transplant Assoc; 1972; 9():409-16. PubMed ID: 4668919
    [No Abstract]   [Full Text] [Related]  

  • 31. Valproate plasma protein binding in the uremic condition.
    Brewster D; Muir NC
    Clin Pharmacol Ther; 1980 Jan; 27(1):76-82. PubMed ID: 6985855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced renal clearance of furancarboxylic acid, a major albumin-bound organic acid, in undialyzed uremic patients.
    Sato M; Koyama M; Miyazaki T; Niwa T
    Nephron; 1996; 74(2):419-21. PubMed ID: 8893167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenylacetylglutamine and hippuric acid in uremic and healthy subjects.
    Zimmerman L; Jörnvall H; Bergström J
    Nephron; 1990; 55(3):265-71. PubMed ID: 2370926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Middle molecule accumulation in uremia: an "extra uremic factor".
    Oulès R; Emond C; Claret G; Branger B; Mion H; Mion C
    Artif Organs; 1981; 4 Suppl():177-83. PubMed ID: 7295089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different protein expression in normal and dysfunctional platelets from uremic patients.
    Marques M; Sacristán D; Mateos-Cáceres PJ; Herrero J; Arribas MJ; González-Armengol JJ; Villegas A; Macaya C; Barrientos A; López-Farré AJ
    J Nephrol; 2010; 23(1):90-101. PubMed ID: 20091492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease.
    McGonigle RJ; Boineau FG; Beckman B; Ohene-Frempong K; Lewy JE; Shadduck RK; Fisher JW
    J Lab Clin Med; 1985 Apr; 105(4):449-58. PubMed ID: 3981057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.
    Niwa T; Ise M
    J Lab Clin Med; 1994 Jul; 124(1):96-104. PubMed ID: 8035108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple and sensitive GC/MS-method for the quantification of urinary phenol, o- and m-cresol and ethylphenols as biomarkers of exposure to industrial solvents.
    Schettgen T; Alt A; Dewes P; Kraus T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jul; 995-996():93-100. PubMed ID: 26046979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood levels of urea nitrogen, phenol, guanidine and creatinine in uremia.
    OLSEN NS; BASSETT JW
    Am J Med; 1951 Jan; 10(1):52-9. PubMed ID: 14799499
    [No Abstract]   [Full Text] [Related]  

  • 40. [Analysis of phenols in uremic serum by gas chromatography-mass spectrometry (author's transl)].
    Niwa T; Maeda K; Kobayashi K; Ohki T
    Nihon Jinzo Gakkai Shi; 1981 Jun; 23(6):777-88. PubMed ID: 7311124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.